MarketInOut Stock Screener Log In | Sign Up

Syngene International Ltd

BSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Syngene International Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeBSE
Market Capitalization161,810 mln
Float191 mln
Earnings Date01/28/2027

EPS

4.62
Stretched

P / E

86.99
Speculative

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.66
Likely reliable

1-Year Forecast

506.25
Strong upside

Relative Strength

90 / 100
Top performer

Business Description

Syngene International Limited is an India-based company that helps pharmaceutical, biotechnology, and other life sciences businesses research, develop, and manufacture new drugs and related products. Working with clients across the United States, Europe, and other global markets, Syngene supports the full journey from early drug discovery through to clinical trials and regulatory submissions. The company handles a wide range of work, including chemistry, biology, safety testing, and data analysis, covering both traditional small-molecule drugs and more complex treatments such as peptides and antibody-drug conjugates. Founded in 1993 and headquartered in Bengaluru, Syngene operates as a subsidiary of Biocon Limited and counts major industry names such as Bristol-Myers Squibb, Baxter, and Amgen among its partners.

Key Fundamentals

EPS4.62
P/E86.99
ROE3.87
RPS87.84
ROIC5.95
ROA2.77
Interest Cover10.49
EBITDA, mln7,449
EV / EBITDA22.22
EV / EBIT55.94
Revenue, mln35,223
EV / Revenue4.70

Quote Details

Last 401.90
Change 3.6 (0.9%)
Open 398.20
Volume 116,341
Turnover 46,757,448
Average Volume 204,663

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio1.37
Current Ratio1.65
Price / Book3.41
Price / Tangible Book3.44
Price / Free Cash Flow27.11
Debt / Equity0.10
Price / Sales4.70
PEG Ratio11.66

Financial Strength

Altman Z-Score6.34
Piotroski F-Score 4 / 9
Beneish M-Score-2.66
Price to Intrinsic Value1.91
Price to Graham Number3.16
1-Year Target Price506.25
Shiller PE Ratio34.39

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.57% 91 / 100   
1 Month 9.15% 92 / 100   
2 Months -0.84% 67 / 100   
6 Months -6.77% 53 / 100   
1 Year -37.27% 23 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog